ARCHIVES

DCE Board Approves Support Contract Recompetition

This article is from The Cancer Letter archive.

Vol. 16 No. 27 | July 6, 1990

Download PDF Visit The Full Archive

Related Articles

List of 100 Highest-Paid NIH Officials

February 12, 2010

New Data Support Claims That Costs Are Higher For Protocol Patients

August 31, 1984

First Chop Awards Made, 17 Others In Negotiation For NCI Program To Upgrade Community Cancer Care

October 24, 1980

Grant Supplements, and Challenge Grants

February 20, 2009

In Brief: ONS, ASCO AACR Meetings Open In St. Louis Next Week; Bristol-Myers Adds Farber, McArdle Grants

April 16, 1982

Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment.

July 30, 2004